Company: JSDA
Filing Date: 2025-07-03
Form Type: S-1
Source: 0001641172-25-017818
Chunk: 54

Company: JONES SODA CO.
Filing Date: 2025-07-03
Form: S-1
Chunk 54
---
 we will have broad discretion in the application and specific allocations of the net proceeds of this offering. We intend to invest the net proceeds we receive from this offering that are not used as described above in short- and intermediate-term, interest-bearing obligations, investment-grade instruments or other securities.

Assuming no exercise of the underwriters’ over-allotment option, each $1.00 increase (decrease) in the assumed public offering price of $ per share would increase (decrease) the net proceeds to us from this offering by approximately $ million, assuming that the number of shares offered by us remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Each 100,000 share increase (decrease) in the number of shares offered in this offering would increase (decrease) the net proceeds to us from this offering by approximately $ million, assuming that the price per share for the offering remains at $ , and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

<div align='center'>DIVIDEND POLICY</div>

We have not paid any dividends on our shares of common stock, and we do not anticipate paying any dividends in the foreseeable future. We intend to retain any future earnings to finance the development and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future. Any future determination related to our dividend policy will be made at the discretion of our Board of Directors after considering our financial condition, results of operations, capital requirements, business prospects and other factors our Board of Directors deems relevant. Accordingly, you may need to sell your shares of our common stock to realize a return on your investment, and you may not be able to sell your shares at or above the price you paid for them.

<div align='center'>CAPITALIZATION</div>

The following table sets forth the cash and capitalization as of March 31, 2025, as follows:

| ● | on               
 an actual basis; |

| ● | on an as adjusted basis, to (i) give effect to the sale of all of the equity interests in our wholly-owned subsidiaries that held our     
 THC infused cannabis business in both the United States and Canada to an independent third party for $3,000,000, including the issuance   
 of the Note, and inventory as set forth in the SPA for approximately $61,000 and (ii) the issuance of 699,493 shares of common stock upon 
 the vesting of restricted stock